Skip to content
Medical Health Aged Care

Redcliffe show their support for people impacted by dementia

Dementia Australia 2 mins read

Redcliffe community members turned up in force last weekend, showing their support for people impacted by dementia whilst getting active to improve their brain health.

 

Participating in the 2025 Memory Walk & Jog at Scarborough Beach Park, more than 620 people walked, ran and jogged to raise an impressive total of $97,700.

 

Dementia Australia CEO Professor Tanya Buchanan extended her gratitude to all who participated, raised funds, spread the word and donated.

 

“There was an outstanding show of support from the Redcliffe community who turned out in such large numbers yet again in support of people impacted by dementia,” Professor Buchanan said.

 

“It was great to see the community supporting Dementia Australia by raising funds and awareness of dementia as well as moving for their brain health, which research shows can help reduce our risk of dementia.”

 

Professor Buchanan also acknowledged everyone who volunteered at the Redcliffe Memory Walk & Jog. 

 

“It is only through the hard work of our wonderful volunteers that the success of this event is possible.”

 

This event was one of 28 Memory Walk & Jog events held across Australia in 2025. Each event offers a wonderful opportunity for people impacted by dementia and their supporters to come together, walk or run, at any fitness level, and to raise money and share stories.

  

Missed this event but want to be involved? Organise your own group or individual walk or jog, with a MyWay event. Choose your own date and location and register at www.memorywalk.com.au/get-involved/mw. 

 

-Ends-

 

Dementia Australia is the source of trusted information, education and services for the estimated more than 433,300 Australians living with dementia, and the more than 1.7 million people involved in their care. We advocate for positive change and support vital research. We are here to support people impacted by dementia, and to enable them to live as well as possible. No matter how you are impacted by dementia or who you are, we are here for you.

For support, please contact the National Dementia Helpline on 1800 100 500. An interpreter service is available. The National Dementia Helpline is funded by the Australian Government. People looking for information can also visit dementia.org.au

Media contacts: Teresa Cong, Senior Media & Communications Advisor, [email protected], 0423 383 564

When talking or writing about dementia please refer to Dementia-Friendly Language Guidelines.

Note to Editors:

Photos and video of previous Memory Walk & Jog events for publication are available for use.

We request, where possible, details for the National Dementia Helpline 1800 100 500 appear alongside news stories about dementia, as these stories often prompt questions or concerns:

If this story has prompted any questions or concerns, please call the National Dementia Helpline 1800 100 500 (24 hours, 7 days a week) or visit dementia.org.au.

Media

More from this category

  • Medical Health Aged Care
  • 11/02/2026
  • 06:31
Breast Cancer Network Australia

She Reached Everest before Taking on Breast Cancer — Now Port Macquarie local tackling Kilimanjaro for First Nations Communities

ProudJawoyn and Wiradjuri woman and Port Macquarie local, Kristal Kinsela, is preparing to climb Mount Kilimanjaro to raise critical support for First Nations people…

  • Contains:
  • Food Beverages, Medical Health Aged Care
  • 11/02/2026
  • 05:30
VicHealth, Australian Medical Association, The George Institute for Global Health

Health leaders push for mandatory Health Star Ratings to protect Australians’ health

Leading health organisations have written to Australia’s food ministers, urging them to make Health Star Ratings mandatory on all packaged foods. They say the…

  • Contains:
  • Medical Health Aged Care
  • 10/02/2026
  • 23:41
Helus Pharma

Helus Pharma Appoints Michael Cola as Chief Executive Officer to Lead Next Phase of Scale and Execution

Former President of Shire PLC’s (“Shire”) Specialty Pharmaceutical business, with more than 30 years of experience across neuroscience, rare disease, and specialty pharmaceuticals, including senior leadership roles at Astra-Merck and AstraZeneca PLCProven leader in late-stage clinical development, global commercialization, and capital formation across central nervous system (“CNS”) programsAppointed as Helus Pharma advances its pipeline toward key clinical milestones, including expected Phase 2 data for HLP004 this quarter and Phase 3 topline data for HLP003 later this yearThis news release constitutes a “designated news release” for the purpose of the Company’s prospectus supplement dated December 30, 2025, to it short form…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.